{
  "id": "clinical#screening_cues_10ff6edb",
  "content": "6C46.71 Stimulant-induced anxiety disorder, including amfetamines,\nmethamfetamine and methcathinone\n6C47.71 Synthetic cathinone-induced anxiety disorder\n6C48.71 Caffeine-induced anxiety disorder\n6C49.71 Hallucinogen-induced anxiety disorder\n6C40.71 Volatile inhalant-induced anxiety disorder\n6C4C.71 MDMA or related drug-induced anxiety disorder\n6C4D.71 Dissociative drug-induced anxiety disorder, including ketamine and\nPCP\n6C4E.71 Anxiety disorder induced by other specified psychoactive substance\n6C4F.71 Anxiety disorder induced by multiple specified psychoactive\nsubstances\n6C4G.71 Anxiety disorder induced by unknown or unspecified specified\npsychoactive substances\nFrom secondary mental or behavioural syndromes associated with\ndisorders and diseases classified elsewhere:\n6E63 Secondary anxiety syndrome\n54 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nObsessive-compulsive and related disorders\n6B20 Obsessive-compulsive disorder\nSpecify level of insight:\n6B20.0 Obsessive-compulsive disorder with fair to good insight\n6B20.1 Obsessive-compulsive disorder with poor to absent insight\n6B20.Z Obsessive-compulsive disorder, unspecified\n6B21 Body dysmorphic disorder\nSpecify level of insight:\n6B21.0 Body dysmorphic disorder with fair to good insight\n6B21.1 Body dysmorphic disorder with poor to absent insight\n6B21.Z Body dysmorphic disorder, unspecified\n6B22 Olfactory reference disorder\nSpecify level of insight:\n6B22.0 Olfactory reference disorder with fair to good insight\n6B22.1 Olfactory reference disorder with poor to absent insight\n6B22.Z Olfactory reference disorder, unspecified\n6B23 Hypochondriasis (health anxiety disorder)",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues 6C46.71 Stimulant-induced anxiety disorder, including amfetamines,\nmethamfetamine and methcathinone\n6C47.71 Synthetic cathinone-induced anxiety disorder\n6C48.71 Caffeine-induced anxiety disorder\n6C49.71 Hallucinogen-induced anxiety disorder\n6C40.71 Volatile inhalant-induced anxiety disorder\n6C4C.71 MDMA or related drug-induced anxiety disorder\n6C4D.71 Dissociative drug-induced anxiety disorder, including ketamine and\nPCP\n6C4E.71 Anxiety disorder induced by other specified psychoactive substance\n6C4F.71 Anxiety disorder induced by multiple specified psychoactive\nsubstances\n6C4G.71 Anxiety disorder induced by unknown or unspecified specified\npsychoactive substances\nFrom secondary mental or behavioural syndromes associated with\ndisorders and diseases classified elsewhere:\n6E63 Secondary anxiety syndrome\n54 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders\nObsessive-compulsive and related disorders\n6B20 Obsessive-compulsive disorder\nSpecify level of insight:\n6B20.0 Obsessive-compulsive disorder with fair to good insight\n6B20.1 Obsessive-compulsive disorder with poor to absent insight\n6B20.Z Obsessive-compulsive disorder, unspecified\n6B21 Body dysmorphic disorder\nSpecify level of insight:\n6B21.0 Body dysmorphic disorder with fair to good insight\n6B21.1 Body dysmorphic disorder with poor to absent insight\n6B21.Z Body dysmorphic disorder, unspecified\n6B22 Olfactory reference disorder\nSpecify level of insight:\n6B22.0 Olfactory reference disorder with fair to good insight\n6B22.1 Olfactory reference disorder with poor to absent insight\n6B22.Z Olfactory reference disorder, unspecified\n6B23 Hypochondriasis (health anxiety disorder) 6c46.71 stimulant-induced lo âu disorder, including amfetamines,\nmethamfetamine and methcathinone\n6c47.71 synthetic cathinone-induced lo âu disorder\n6c48.71 caffeine-induced lo âu disorder\n6c49.71 hallucinogen-induced lo..."
}